Dr. Jay Ciezki
Overview
Jay Ciezki is a Radiation Oncologist in Cleveland, Ohio. Dr. Ciezki has been practicing medicine for over 37 years and is rated as an Experienced provider by MediFind in Atherectomy. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Cholangiocarcinoma (Bile Duct Cancer), Prostatectomy, and Atherectomy.
His clinical research consists of co-authoring 70 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Atherectomy.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE-MEDICAID PLAN
- HMO
- EPO
- HMO
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- MEDICARE SNP
- MEDICARE MAPD
- OTHER MEDICARE
- INSURANCE PLAN
- MEDICARE PDP
- PPO
- EPO
- HMO
- PPO
- EPO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER MEDICARE
- POS
- PPO
- OTHER MANAGED MEDICAID
- HMO
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- EPO
- HMO
- INDEMNITY
- PPO
- MEDICARE MAPD
- MEDICARE PDP
- OTHER MEDICARE PART D
- MEDICARE SNP
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- HMO
- PPO
- OTHER COMMERCIAL
- HMO
- MANAGED MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
- INSURANCE PLAN
- MEDICARE MAPD
- EPO
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
10201 Carnegie Avenue, Cleveland, OH 44106
2050 East 96th Street, Cleveland, OH 44106
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Cleveland Clinic Main Campus
Sheen Cherian is a Radiation Oncologist in Cleveland, Ohio. Dr. Cherian is rated as a Distinguished provider by MediFind in Atherectomy. His top areas of expertise are Marginal Zone Lymphoma (MZL), Cervical Cancer, Endometrial Cancer, Neuroendocrine Carcinoma of the Cervix, and Atherectomy.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Prostate CancerDr. Ciezki isElite. Learn about Prostate Cancer.
- Distinguished
- Familial Prostate CancerDr. Ciezki isDistinguished. Learn about Familial Prostate Cancer.
- ProstatectomyDr. Ciezki isDistinguished. Learn about Prostatectomy.
- Advanced
- Atypical Teratoid Rhabdoid Tumor (ATRT)
- Brain TumorDr. Ciezki isAdvanced. Learn about Brain Tumor.
- Cholangiocarcinoma (Bile Duct Cancer)
- Embryonal Tumor with Multilayered Rosettes
- EpendymomaDr. Ciezki isAdvanced. Learn about Ependymoma.
- GlioblastomaDr. Ciezki isAdvanced. Learn about Glioblastoma.
- Experienced
- Acinic Cell Carcinoma of Salivary Glands
- Adenoid Cystic CarcinomaDr. Ciezki isExperienced. Learn about Adenoid Cystic Carcinoma.
- AstrocytomaDr. Ciezki isExperienced. Learn about Astrocytoma.
- AtherectomyDr. Ciezki isExperienced. Learn about Atherectomy.
- Bone TumorDr. Ciezki isExperienced. Learn about Bone Tumor.
- Endometrial CancerDr. Ciezki isExperienced. Learn about Endometrial Cancer.